Buy 5 or more, save 35% · code

Back to Catalog

Peptides

AOD-9604 5 mg

$89Per Unit

Modified cyclic peptide fragment maintaining lipolytic properties without affecting IGF-1 levels. Packaged under sterile inert gas with verified HPLC purity.

Lot AOD2026-03C · COA on request
Lyophilized peptide, sterile vial, 5 mg fill
2–8°C (stable 30 days)

1 × $89.00 = $89.00

4 more units of anything - mix and match - unlocks 35% off with code EHAB35.

AOD-9604 5 mg

$89.00

Research use only
AOD-9604 5 mg research packaging
Lyophilized peptide, sterile vial, 5 mg fill
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot AOD2026-03C) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

AOD-9604

Regulatory status
Not approved. FDA lists AOD-9604 among substances that may present significant safety risks in compounding and notes serious adverse events that may be associated with it, causality unclear.
Strongest evidence
Animal metabolic studies; obesity drug development did not produce an approved product
Overview

AOD-9604 is a synthetic fragment from the C-terminal region of human growth hormone, originally developed as an anti-obesity drug.

What researchers study it for
  • Fat metabolism (lipolysis) in animal models
  • Cartilage in a rabbit osteoarthritis model
Mechanism

Designed to reproduce growth hormone's fat-metabolism effects without its growth-promoting effects.

Evidence (3)
  1. Animal study

    Metabolic studies (Horm Res 2000)

    Characterized the lipolytic (fat-breakdown) activity of the synthetic growth-hormone fragment.[1]

  2. Animal study

    Rabbit osteoarthritis model (2015)

    Intra-articular injection with or without hyaluronic acid in rabbits.[2]

  3. Regulatory

    FDA compounding risk list

    Listed, with serious adverse events reported whose causality is unclear.[3]

Limitations of the evidence
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (3)
  1. 1.Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormoneNg FM et al. Horm Res. 2000 Animal study
  2. 2.Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis ModelKwon DR, Park GY. Ann Clin Lab Sci. 2015 Animal study
  3. 3.Certain bulk drug substances for use in compounding that may present significant safety risks (lists AOD-9604)U.S. FDA, page current as of Apr 22, 2026 Regulatory
Every published studyPubMed search: AOD-9604(opens in a new tab)Every registered trialClinicalTrials.gov search: AOD-9604(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.